The National Institutes of Health announced on Monday that the biomedical agency will no longer award funding to new grant ...

The Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), hosted a workshop ...

Hopkins expert Thomas Hartung discusses an announcement by the nation's largest biomedical research funder that it will no longer consider grant proposals that do not include alternative testing model ...

In a historic move, the U.S. National Institutes of Health (NIH) announced today that it will no longer seek research ...

The announcement, made by Acting NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives (DPCPSI), ...

Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to ...

The massive stakes of the Trump administration’s plans to end animal testing Is Trump doing the right thing on animal research for the wrong reasons?

The end to animal testing marks the beginning of better biomedicine Animal models have become obsolete A technician holds a laboratory mouse at the University of Geneva.

Lastly, the NIH will publicly report on research spending annually to measure progress toward reduction of funding for animal studies and increase for human-based approaches.

The NIH’s move away from animal testing comes two weeks after the Food & Drug Administration said it would stop testing monoclonal antibodies and other drugs on animals.

Both the NIH and FDA are phasing out animal testing for what their scientists believe are more effective and humane research.

By shifting from animals to an exclusively human optimization preclinical process, Vivodyne has raised $40 million in new Series A financing to scale its robotics+AI approach to testing on ...